Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Vitamin C  COVID-19 treatment studies for Vitamin C  C19 studies: Vitamin C  Vitamin C   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
Vitamin C inhibits SARS coronavirus-2 main protease essential for viral replication
Malla et al., bioRxiv, doi:10.1101/2021.05.02.442358 (Preprint)
Malla et al., Vitamin C inhibits SARS coronavirus-2 main protease essential for viral replication, bioRxiv, doi:10.1101/2021.05.02.442358 (Preprint)
May 2021   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
In Vitro study showing that vitamin C inhibits SARS-CoV-2 3CLpro. Authors note that the different clinical results may be explained in part by the widely varying dosages used, and they conclude that vitamin C and/or derivatives may become an important treatment for COVID-19 and other viral infections.
Malla et al., 3 May 2021, preprint, 9 authors.
In Silico studies are an important part of preclinical research, however results may be very different in vivo.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperVitamin CAll
Abstract: bioRxiv preprint doi: https://doi.org/10.1101/2021.05.02.442358; this version posted May 20, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 1 2 3 Vitamin C Binds to SARS Coronavirus-2 Main Protease Essential for Viral Replication 4 5 Tek Narsingh Malla1&, Suraj Pandey1&, Luis Aldama2, Dennisse Feliz2, 3, Moraima Noda2, 6 Ishwor Poudyal1, George N. Phillips Jr.4, Emina A. Stojković2*, Marius Schmidt1* 7 8 1 Department of Physics, University of Wisconsin Milwaukee, Milwaukee, WI 53211 USA 9 2 Department of Biology, Northeastern Illinois University, Chicago, IL 60625 USA 10 3 Department of Chemistry, Northeastern Illinois University, Chicago, IL 60625 USA 11 4 Department of BioSciences, Rice University, Houston, TX 77005 USA 12 & 13 *corresponding authors contributed equally 14 15 Abstract 16 There is an urgent need for anti-viral agents that treat and/or prevent Covid-19 caused by SARS- 17 Coronavirus (CoV-2) infections. The replication of the SARS CoV-2 is dependent on the activity 18 of two cysteine proteases, a papain-like protease, PL-pro, and the 3C-like protease known as 19 main protease Mpro or 3CLpro. The shortest and the safest path to clinical use is the repurposing 20 of drugs with binding affinity to PLpro or 3CLpro that have an established safety profile in 21 humans. Several studies have reported crystal structures of SARS-CoV-2 main protease in 22 complex with FDA approved drugs such as those used in treatment of hepatitis C. Here, we 23 report the crystal structure of 3CLpro in complex Vitamin C (L-ascorbate) bound to the protein's 24 active site at 2.5 Ångstrom resolution. The crystal structure of the Vitamin C 3CLpro complex 25 may aid future studies on the effect of Vitamin C not only on the coronavirus main protease but 26 on related proteases of other infectious viruses. 27 28 bioRxiv preprint doi: https://doi.org/10.1101/2021.05.02.442358; this version posted May 20, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 2 29 a ASC FTE His41 His163 Cys145 subunit A subunit B b FTE c ASC DTT His41 Cys145 Cys145 His163 His41 His163 Figure 1. Vitamin C and DTT bound in the active site of SARS CoV-2 3CLpro. (a) The 3CLpro dimer in the asymmetric unit of the orthorhombic crystals soaked with L-ascorbate. Polder difference electron density (Liebschner et al., 2017) in the active sites is shown in green (contour: 2.5 sigma). (b) The L-ascorbate (ASC) in subunit B. The ASC interacts with the catalytic Cys-145 and is stabilized by a hydrogen bond to His-163. A trifluoroethanol (FTE) is located close to the ASC. (c) Dithiothreitol (DTT) is observed in monoclinic (C2) crystal form. It does not bind to Cys-41. It rather binds to His-41 forming a sulfenamide. Difference electron density maps shown in (a) - (c) are obtained after refining the 3CLpro without the addition of ligand. The ascorbate and DTT explain the additional electron density. 30 The Covid-19 pandemic, caused by a novel severe acute respiratory syndrome (SARS) 31 coronavirus 2, has paralyzed public life..
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit